Latest news
HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - TradingViewTradingView · Fri, 07 Aug 2026 21:52:00 GMTWhy Health Catalyst (HCAT) Shares Are Trading Lower Today - TradingViewTradingView · Fri, 07 Aug 2026 16:30:51 GMT5 Revealing Analyst Questions From BrightSpring Health Services’s Q2 Earnings Call - TradingViewTradingView · Fri, 07 Aug 2026 05:47:00 GMTHCAT: Q2 2026 beat guidance, divestiture enabled debt repayment, and 2026 outlook reflects transformation - TradingViewTradingView · Thu, 06 Aug 2026 22:15:20 GMTHealth Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:22:06 GMTHCAT: Q2 2026 revenue fell 13% YoY; Vitalware sale enabled debt repayment but future margins face headwinds - TradingViewTradingView · Thu, 06 Aug 2026 20:59:35 GMTHCAT: Q2 2026 revenue fell 13% but adjusted EBITDA grew 6%, with full-year revenue guided at $246M–$249M - TradingViewTradingView · Thu, 06 Aug 2026 20:14:12 GMTBRIEF-Health Catalyst Q2 Net Income USD -40.537 Million - TradingViewTradingView · Thu, 06 Aug 2026 20:04:01 GMT